Skip to main content
OpenTrials
Completed

NCT Number: NCT01843907

Patient Participation in Prevention of Loss of Functions

Randomized Clinical Trial (RCT) To investigate and compare the effect of two preventive interventions on readmission rates, loss of functions, quality of life and cost-benefit.

Completed

Looking for future studies?

Notify Me

Key information

About this study

At baseline:

Nutritional status, BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test), quality of life (EQ5D), coping (Sense of Coherence 13 item scale), patient experience (NORPEQ), medication management (MedMaide).

At follow-up three months after discharge:

BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test) and EQ5D. In addition, need for initiated municipal assistance after discharge. Project employee who performs data collection is blinded to the group to which the patient is randomized.

The control group Patients in the control group undergo the same measurements and registrations at discharge and 3 - month follow-up, as the intervention groups, but receive otherwise usual treatment and care, and are discharged without further intervention. After six months control patients receive a report comprising the screening results, relevant information material and a cover letter. Patients' GP and municipality care section receive a summary of outcomes, as well as a cover letter.

Register data Information on mortality, readmissions and services in primary health care are obtained after 6 months from the National Patient Register, Population Register and municipalities.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 65 years or older
  • Living in their own home with no contact to the Municipality, both before and after admission
  • Discharged from Department o105 or the Acute Receiving Unit <48 hours from admission.

Exclusion criteria

  • Patients with life-threatening disease in the terminal stage
  • Patients who does not speak and understand Danish
  • Patients who are not able to communicate and collaborate, with regards to the measurements

Treatment and study plan

Empowerment

Behavioral

To give patients the necessary resources to take care of their own health

Conversation with nurse

Other

To find out, if the nurse, using her ....

Primary outcomes

  1. Number of participants who have been readmitted to hospital

    Time frame: 01.03.2013 - 12.31.2014

    Number of participants who have been readmitted to hospital. Measured 6 months after admission.

Secondary outcomes

  1. Mortality

    Time frame: 01.04.2014 - 31.12.2014

    Mortality. Number of participants, who have died. Measured 6 months after admission.

  2. Functional ability

    Time frame: 31.12.2014

    Measured 3 months after discharge.

    Functional ability

    Handgrip-strength 4 second test: Hand- and forearm muscular strength in kg. and 30 second chair stand test: Lower-body muscle strength

  3. Primary Healthcare Services

    Time frame: 01.04.2013 - 31.12.2014

    Delivered services in Primary Healthcare. Measured 6 months after admission.

Sponsors and collaborators

Lead sponsor

Herlev Hospital

Other

Registry information

Official study title

Cross-sectorial Patient Participation in Prevention of Loss of Functions in Older Short-stay Medical Patients

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
May 1, 2013
Registry last updated
Jul 31, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.